Viking Therapeutics Inc (VKTX) support and resistance · $3.97B cap
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
This page maps Viking Therapeutics Inc (VKTX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VKTX revenue for 2026-06-30 was $0. Net income was -$286.3M. VKTX currently screens at market cap $3.97B.
VKTX currently screens at market cap $3.97B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VKTX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VKTX quote page for the session range and the stock page for the full model.
Not investment advice.